Let's get functional: Drug sensitivity profiling to enable precision sarcoma medicine.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39366358.
- Also identified by DOI 10.1016/j.stem.2024.09.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drug sensitivity profiling in patient-derived tumor models offers new hope for improving outcomes in cancers lacking effective therapies. Al Shihabi et al.<sup>1</sup> demonstrate that short-term cultures from bone and soft tissue sarcomas enable clinically meaningful screening of multiple drugs and combinations, marking a significant advance in personalized care for these high-risk diseases.
Medical subject headings
- Sarcoma
- Precision Medicine